News
Together with the Imperial College London and Inmunotek, Madrid ClinCompetence Cologne present the results of a first-in-human study
Together with Sanofi, Frankfurt, Germany, ClinCompetence publishes results of a large prospective, randomized, controlled clinical trial with Ectoin Mouth and Throat Spray in patients suffering from Acute Pharyngitis and Dry Cough.
Effectiveness and Tolerability of Ectoin® Mouth and Throat Spray Althaea Honey (ERS09) for Sore Throat due to Acute Pharyngitis and Dry Cough: A Multicentre,...
September 12th, 2023 Milano:
ClinCompetence Cologne present a poster at the International Congress of the European Respiratory Society (ERS) Responder rates in patients with acute cough...
ClinCompetence contribute to a successful phase III study in grass pollen allergy published by Allergy Therapeutics PLC, Worthing, UK in the Journal “Allergy”
Short-course subcutaneous treatment with PQ Grass strongly improves symptom and medication scores in grass allergy Article DOI: 10.1111/all.15788
EAACI 2023 Hamburg, Germany: Together with Inmunotek, Madrid, Spain, ClinCompetence Cologne present the complete results of the betMan development program in birch pollen-induced rhinoconjunctivitis.
Clinical Development of Mannan conjugated birch pollen allergoids for the treatment of birch pollen allergic patients – from first-in-human to clinical validation in 3 studies
Affiliations Ralph Mösges, PhD, MD FAAAAI Esther Raskopf, PhD Silke Allekotte, PhD Mandy Cuevas, MD Enrique Fernandez-Caldas, PhD José. L. Subiza, MD, PhD...
Subcutaneous immunotherapy with mannan-conjugated birch pollen allergoids is safe and well tolerated – data from 3 sequential trials
Affiliations Silke Allekotte, PhD Esther Raskopf, PhD Laura England Christian Neuhof Hacer Sahin, PhD Lea Radtke, PhD Christoph Zeyen Lea Decker Elena...
Mannan-conjugated birch pollen allergoids reduce the combined symptom and medication score in birch pollen allergic patients already in the first treatment year and further decreases with prolonged treatment duration
Affiliations Laura England Esther Raskopf, PhD Hacer Sahin, PhD Lea Radtke, PhD Christoph Zeyen Lea Decker Elena Xenofontos Friederike Hüffmeier Mandy Cuevas,...
Subcutaneous immunotherapy with mannan-conjugated birch pollen allergoids shows long-term effects already after 2 years of treatment by inducing a significant immune response in birch pollen allergic patients
Affiliations Esther Raskopf, PhD Laura England Hacer Sahin, PhD Lea Radtke, PhD Christoph Zeyen Lea Decker Friederike Hüffmeier Elena Xenofontos Mandy Cuevas,...
EAACI Prague, 1-3 July 2022
CCC presents results of two-year treatment of birch pollen allergy with mannan-conjugated allergoids. CCC presents first results of a two-year...